{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:36:26Z","timestamp":1793050586428,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jtct.2026.10.009","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:15:38Z","timestamp":1791562538000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Abatacept in Combination With ATLG Reduces Acute GvHD Incidence and Improves Outcomes of Children Transplanted From Mismatched Unrelated Donors: A Real-World, Multicenter, Retrospective Study"],"prefix":"10.1016","author":[{"given":"Francesco","family":"Quagliarella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Becci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Buechner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Becilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Zecca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ester","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Lucchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Masetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Perdichizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Faraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Tumino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franca","family":"Fagioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Giuseppina","family":"Cefalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingvild","family":"Heier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Boccieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Andreani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Pagliara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Algeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Merli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jtct.2026.10.009_bib0001","article-title":"Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation Registry Retrospective Analysis","volume":"6","author":"Shouval","year":"2019","journal-title":"Lancet Haematol"},{"issue":"24","key":"10.1016\/j.jtct.2026.10.009_bib0002","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1182\/blood-2018-07-861575","article-title":"Unrelated donor vs HLA-haploidentical alpha\/beta T-cell- and B-cell-depleted HSCT in children with acute leukemia","volume":"132","author":"Bertaina","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtct.2026.10.009_bib0003","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","article-title":"International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium","volume":"22","author":"Harris","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2026.10.009_bib0004","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2011-06-364265","article-title":"Risk factors for acute GVHD and survival after hematopoietic cell transplantation","volume":"119","author":"Jagasia","year":"2012","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jtct.2026.10.009_bib0005","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3324\/haematol.2015.138180","article-title":"Expanding transplant options to patients over 50 years. improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the acute leukemia working party of the EBMT","volume":"101","author":"Savani","year":"2016","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.jtct.2026.10.009_bib0006","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1182\/blood.V83.12.3815.3815","article-title":"In vivo blockade of CD28\/CTLA4: B7\/BB1 interaction with CTLA4-ig reduces lethal murine graft-versus-host disease across the major histocompatibility complex barrier in mice","volume":"83","author":"Blazar","year":"1994","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jtct.2026.10.009_bib0007","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1172\/JCI98793","article-title":"CD28 blockade controls T cell activation to prevent graft-versus-host disease in primates","volume":"128","author":"Watkins","year":"2018","journal-title":"J Clin Invest"},{"issue":"11","key":"10.1016\/j.jtct.2026.10.009_bib0008","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.bbmt.2013.09.003","article-title":"In vivo T cell costimulation blockade with abatacept for acute graft-versus-host disease prevention: a first-in-disease trial","volume":"19","author":"Koura","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.jtct.2026.10.009_bib0009","article-title":"Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the european society for blood and marrow transplantation","volume":"11","author":"Penack","year":"2024","journal-title":"Lancet Haematol"},{"issue":"11","key":"10.1016\/j.jtct.2026.10.009_bib0010","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41409-023-02034-z","article-title":"Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7\/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis","volume":"58","author":"Raghunandan","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"17","key":"10.1016\/j.jtct.2026.10.009_bib0011","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1200\/JCO.20.01086","article-title":"Phase II trial of costimulation blockade with abatacept for prevention of acute GVHD","volume":"39","author":"Watkins","year":"2021","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.jtct.2026.10.009_bib0012","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/leu.2012.66","article-title":"The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation","volume":"26","author":"Lion","year":"2012","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.jtct.2026.10.009_bib0013","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.32085","article-title":"Abatacept prevents severe acute graft-versus-host disease without increasing graft failure risk in pediatric bone marrow failure syndromes","volume":"72","author":"Hudda","year":"2025","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"10.1016\/j.jtct.2026.10.009_bib0014","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S1470-2045(17)30417-5","article-title":"Efficacy of two different doses of rabbit anti-T-lymphocyte globulin to prevent graft-versus-host disease in children with haematological malignancies transplanted from an unrelated donor: a multicentre, randomised, open-label, phase 3 trial","volume":"18","author":"Locatelli","year":"2017","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.jtct.2026.10.009_bib0015","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/s41409-021-01378-8","article-title":"EBMT\/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity","volume":"56","author":"Lankester","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2026.10.009_bib0016","series-title":"NIH Chronic Graft-Versus-Host Disease Consensus Conference 2025 Update","first-page":"678","volume":"31","author":"Lee","year":"2025"},{"issue":"10","key":"10.1016\/j.jtct.2026.10.009_bib0017","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.bmt.1703260","article-title":"Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part I: unadjusted analysis","volume":"28","author":"Klein","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2026.10.009_bib0018","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1365-2141.1993.tb04697.x","article-title":"Summarizing data on survival, relapse, and chronic graft-versus-host disease after bone marrow transplantation: motivation for and description of new methods","volume":"83","author":"Pepe","year":"1993","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.jtct.2026.10.009_bib0019","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1182\/blood-2014-10-609032","article-title":"Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation","volume":"125","author":"Holtan","year":"2015","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jtct.2026.10.009_bib0020","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/sj.bmt.1703271","article-title":"Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: regression modeling","volume":"28","author":"Klein","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.jtct.2026.10.009_bib0021","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1182\/bloodadvances.2021005208","article-title":"Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation","volume":"6","author":"Qayed","year":"2022","journal-title":"Blood Adv"},{"issue":"10","key":"10.1016\/j.jtct.2026.10.009_bib0022","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/bloodadvances.2022008545","article-title":"Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure","volume":"7","author":"Stenger","year":"2023","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.jtct.2026.10.009_bib0023","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1506002","article-title":"Antilymphocyte globulin for prevention of chronic graft-versus-host disease","volume":"374","author":"Kroger","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jtct.2026.10.009_bib0024","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1182\/bloodadvances.2021005628","article-title":"TCRalphabeta\/CD19 depleted HSCT from an HLA-haploidentical relative to treat children with different nonmalignant disorders","volume":"6","author":"Merli","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2026.10.009_bib0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.trim.2017.07.004","article-title":"T cell costimulation blockade promotes transplantation tolerance in combination with sirolimus and post-transplantation cyclophosphamide for haploidentical transplantation in children with severe aplastic anemia","volume":"43-44","author":"Jaiswal","year":"2017","journal-title":"Transpl Immunol"},{"issue":"16","key":"10.1016\/j.jtct.2026.10.009_bib0026","first-page":"3894","article-title":"Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease","volume":"4","author":"Ngwube","year":"2020","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.jtct.2026.10.009_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2025.12.372","article-title":"Acute GVHD suppression using co-stimulatory blockade with abatacept to expand non-malignant transplant: preliminary results from the multicenter ascent trial","volume":"32","author":"Stenger","year":"2026","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2026.10.009_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtct.2026.07.021","article-title":"Real-world analysis of post-transplant cyclophosphamide on allogeneic HCT landscape","author":"Sebastian","year":"2026","journal-title":"Transplant Cell Ther"},{"issue":"25","key":"10.1016\/j.jtct.2026.10.009_bib0029","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1056\/NEJMoa2215943","article-title":"Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis","volume":"388","author":"Bolanos-Meade","year":"2023","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.jtct.2026.10.009_bib0030","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1200\/JCO-25-00856","article-title":"Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis after mismatched unrelated donor peripheral blood stem cell transplantation","volume":"43","author":"Al Malki","year":"2025","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.jtct.2026.10.009_bib0031","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1600-6143.2010.03026.x","article-title":"Belatacept: the promises and challenges of belatacept and costimulatory blockade","volume":"10","author":"Kaplan","year":"2010","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.jtct.2026.10.009_bib0032","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1111\/ajt.15321","article-title":"Impact of selective CD28 blockade on virus-specific immunity to a murine Epstein-Barr virus homolog","volume":"19","author":"Crepeau","year":"2019","journal-title":"Am J Transplant"},{"issue":"1","key":"10.1016\/j.jtct.2026.10.009_bib0033","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/bmt.2011.28","article-title":"In vivo B-cell depletion with rituximab for alternative donor hemopoietic SCT","volume":"47","author":"Dominietto","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.jtct.2026.10.009_bib0034","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood-2017-04-779769","article-title":"Outcome of children with acute leukemia given HLA-haploidentical HSCT after alphabeta T-cell and B-cell depletion","volume":"130","author":"Locatelli","year":"2017","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.jtct.2026.10.009_bib0035","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jtct.2026.10.009_bib0036","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1365-2141.2010.08409.x","article-title":"Lymphocyte subset reconstitution after unrelated cord blood or bone marrow transplantation in children","volume":"152","author":"Renard","year":"2011","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.jtct.2026.10.009_bib0037","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.bbmt.2007.07.005","article-title":"Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation","volume":"13","author":"Savani","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.jtct.2026.10.009_bib0038","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jcyt.2021.09.011","article-title":"An ISCT stem cell engineering committee position statement on immune reconstitution: the importance of predictable and modifiable milestones of immune reconstitution to transplant outcomes","volume":"24","author":"Bertaina","year":"2022","journal-title":"Cytotherapy"},{"issue":"5","key":"10.1016\/j.jtct.2026.10.009_bib0039","article-title":"Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis","volume":"2","author":"Admiraal","year":"2015","journal-title":"Lancet Haematol"},{"issue":"2","key":"10.1016\/j.jtct.2026.10.009_bib0040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.bbmt.2015.08.028","article-title":"Immune reconstitution after allogeneic hematopoietic cell transplantation in children","volume":"22","author":"de Koning","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"17","key":"10.1016\/j.jtct.2026.10.009_bib0041","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1182\/blood.2023023660","article-title":"Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation","volume":"144","author":"Kean","year":"2024","journal-title":"Blood"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672600792X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266663672600792X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:08:26Z","timestamp":1793048906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266663672600792X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":41,"alternative-id":["S266663672600792X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2026.10.009","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abatacept in Combination With ATLG Reduces Acute GvHD Incidence and Improves Outcomes of Children Transplanted From Mismatched Unrelated Donors: A Real-World, Multicenter, Retrospective Study","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2026.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}